| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase binding | RGPD4 DENND5B KNTC1 RGPD2 BIN1 RIN3 PIH1D2 ASB15 DOCK5 CYRIA RGPD3 IPO13 | 8.29e-05 | 360 | 175 | 12 | GO:0051020 |
| GeneOntologyMolecularFunction | histone binding | 1.20e-04 | 265 | 175 | 10 | GO:0042393 | |
| GeneOntologyMolecularFunction | small GTPase binding | RGPD4 DENND5B KNTC1 RGPD2 RIN3 PIH1D2 ASB15 DOCK5 CYRIA RGPD3 IPO13 | 1.29e-04 | 321 | 175 | 11 | GO:0031267 |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 1.37e-04 | 12 | 175 | 3 | GO:0017154 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.90e-04 | 18 | 175 | 3 | GO:0008569 | |
| GeneOntologyBiologicalProcess | gonadal mesoderm development | 7.45e-14 | 9 | 168 | 7 | GO:0007506 | |
| GeneOntologyBiologicalProcess | mesoderm development | 5.75e-06 | 157 | 168 | 9 | GO:0007498 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 4.30e-05 | 9 | 168 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 6.11e-05 | 10 | 168 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | 6.41e-05 | 122 | 168 | 7 | GO:0006334 | |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 6.44e-05 | 52 | 168 | 5 | GO:0071526 | |
| GeneOntologyBiologicalProcess | determination of left/right asymmetry in nervous system | 6.60e-05 | 2 | 168 | 2 | GO:0035545 | |
| GeneOntologyBiologicalProcess | olfactory nerve formation | 6.60e-05 | 2 | 168 | 2 | GO:0021628 | |
| GeneOntologyBiologicalProcess | G protein-coupled opioid receptor signaling pathway | 1.43e-04 | 13 | 168 | 3 | GO:0038003 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.43e-04 | 13 | 168 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 1.66e-04 | 142 | 168 | 7 | GO:0034728 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.81e-04 | 14 | 168 | 3 | GO:1903299 | |
| GeneOntologyBiologicalProcess | olfactory nerve morphogenesis | 1.97e-04 | 3 | 168 | 2 | GO:0021627 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | 2.11e-04 | 249 | 168 | 9 | GO:0065004 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 3.03e-05 | 8 | 173 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 6.41e-05 | 10 | 173 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 1.50e-04 | 13 | 173 | 3 | GO:0002116 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.90e-04 | 14 | 173 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 4.15e-04 | 18 | 173 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 5.73e-04 | 20 | 173 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 6.64e-04 | 21 | 173 | 3 | GO:0106068 | |
| Domain | ARM-type_fold | CLTCL1 USP9X USP24 USP9Y TRRAP DOCK5 ARFGEF3 THADA PLAA LTN1 HEATR9 IPO13 INTS4 HEATR3 | 1.58e-06 | 339 | 162 | 14 | IPR016024 |
| Domain | NAP_family | 1.19e-05 | 17 | 162 | 4 | IPR002164 | |
| Domain | NAP | 1.19e-05 | 17 | 162 | 4 | PF00956 | |
| Domain | Rab_bind | 2.19e-05 | 7 | 162 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 2.19e-05 | 7 | 162 | 3 | IPR032023 | |
| Domain | Plexin_cytopl | 5.18e-05 | 9 | 162 | 3 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 5.18e-05 | 9 | 162 | 3 | IPR013548 | |
| Domain | Plexin | 5.18e-05 | 9 | 162 | 3 | IPR031148 | |
| Domain | - | 7.35e-05 | 10 | 162 | 3 | 1.10.220.60 | |
| Domain | IPT | 8.19e-05 | 27 | 162 | 4 | SM00429 | |
| Domain | Grip | 1.00e-04 | 11 | 162 | 3 | SM00755 | |
| Domain | GRIP | 1.00e-04 | 11 | 162 | 3 | PF01465 | |
| Domain | ARM-like | 1.27e-04 | 270 | 162 | 10 | IPR011989 | |
| Domain | Ran_BP1 | 1.33e-04 | 12 | 162 | 3 | PF00638 | |
| Domain | RANBD1 | 1.33e-04 | 12 | 162 | 3 | PS50196 | |
| Domain | GRIP_dom | 1.33e-04 | 12 | 162 | 3 | IPR000237 | |
| Domain | GRIP | 1.33e-04 | 12 | 162 | 3 | PS50913 | |
| Domain | TIG | 1.43e-04 | 31 | 162 | 4 | PF01833 | |
| Domain | IPT | 1.62e-04 | 32 | 162 | 4 | IPR002909 | |
| Domain | RanBD | 1.72e-04 | 13 | 162 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 1.72e-04 | 13 | 162 | 3 | IPR000156 | |
| Domain | TPR-like_helical_dom | 2.03e-04 | 233 | 162 | 9 | IPR011990 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.17e-04 | 14 | 162 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.17e-04 | 14 | 162 | 3 | IPR024743 | |
| Domain | MT | 2.17e-04 | 14 | 162 | 3 | PF12777 | |
| Domain | AAA_8 | 2.17e-04 | 14 | 162 | 3 | PF12780 | |
| Domain | DHC_fam | 2.70e-04 | 15 | 162 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.70e-04 | 15 | 162 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.70e-04 | 15 | 162 | 3 | IPR004273 | |
| Domain | Opioid_rcpt | 4.44e-04 | 4 | 162 | 2 | IPR001418 | |
| Domain | Golgin_A_7/ERF4 | 4.44e-04 | 4 | 162 | 2 | IPR019383 | |
| Domain | Erf4 | 4.44e-04 | 4 | 162 | 2 | PF10256 | |
| Domain | NT-C2 | 4.44e-04 | 4 | 162 | 2 | PF10358 | |
| Domain | NT-C2 | 4.44e-04 | 4 | 162 | 2 | IPR019448 | |
| Domain | - | 4.57e-04 | 207 | 162 | 8 | 1.25.40.10 | |
| Domain | TPR_REGION | 5.99e-04 | 165 | 162 | 7 | PS50293 | |
| Domain | TPR | 5.99e-04 | 165 | 162 | 7 | PS50005 | |
| Domain | Autophagy-rel_C | 7.35e-04 | 5 | 162 | 2 | IPR015412 | |
| Domain | ATG_C | 7.35e-04 | 5 | 162 | 2 | PF09333 | |
| Domain | DUF3585 | 1.53e-03 | 7 | 162 | 2 | IPR022735 | |
| Domain | DUF3585 | 1.53e-03 | 7 | 162 | 2 | PF12130 | |
| Domain | TPR-contain_dom | 1.99e-03 | 150 | 162 | 6 | IPR013026 | |
| Domain | Chorein_N | 2.02e-03 | 8 | 162 | 2 | PF12624 | |
| Domain | DHC_N1 | 2.02e-03 | 8 | 162 | 2 | PF08385 | |
| Domain | VPS13_N | 2.02e-03 | 8 | 162 | 2 | IPR026854 | |
| Domain | Dynein_heavy_dom-1 | 2.02e-03 | 8 | 162 | 2 | IPR013594 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 6.29e-07 | 9 | 121 | 4 | MM15030 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 4.84e-06 | 14 | 121 | 4 | M7578 | |
| Pubmed | Zic4, a zinc-finger transcription factor, is expressed in the developing mouse nervous system. | 6.34e-10 | 4 | 176 | 4 | 15895369 | |
| Pubmed | RARS1 USP9X STAT1 ARFGEF3 THADA PLAA LTN1 IPO13 EXOC7 HEATR3 | 3.62e-08 | 183 | 176 | 10 | 23956138 | |
| Pubmed | 1.27e-07 | 3 | 176 | 3 | 22024047 | ||
| Pubmed | 1.27e-07 | 3 | 176 | 3 | 14679585 | ||
| Pubmed | Overlapping and distinct expression domains of Zic2 and Zic3 during mouse gastrulation. | 1.27e-07 | 3 | 176 | 3 | 15261827 | |
| Pubmed | The mouse zic gene family. Homologues of the Drosophila pair-rule gene odd-paired. | 1.27e-07 | 3 | 176 | 3 | 8557628 | |
| Pubmed | CD spectra show the relational style between Zic-, Gli-, Glis-zinc finger protein and DNA. | 1.30e-07 | 10 | 176 | 4 | 18298960 | |
| Pubmed | Spatiotemporal expression of Zic genes during vertebrate inner ear development. | 1.30e-07 | 10 | 176 | 4 | 23606270 | |
| Pubmed | RGPD4 EHBP1 RGPD2 BIN1 RARS1 EMC4 USP9X ATG2B USP24 ARCN1 GRAMD1B ARFGEF3 GRK2 PLAA PPP5C SUGP2 UBE2N ABCE1 RGPD3 BAIAP2 ALDOA | 3.61e-07 | 1139 | 176 | 21 | 36417873 | |
| Pubmed | Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. | 5.08e-07 | 4 | 176 | 3 | 9502813 | |
| Pubmed | 5.08e-07 | 4 | 176 | 3 | 11306810 | ||
| Pubmed | 5.08e-07 | 4 | 176 | 3 | 11053430 | ||
| Pubmed | PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure. | 5.08e-07 | 4 | 176 | 3 | 25518740 | |
| Pubmed | An Evolutionarily Conserved Mesodermal Enhancer in Vertebrate Zic3. | 5.08e-07 | 4 | 176 | 3 | 30297839 | |
| Pubmed | 5.08e-07 | 4 | 176 | 3 | 7931345 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | PLXNA3 CLTCL1 ABCA13 USP9X ZSWIM6 ZIC1 DOCK5 GRAMD1B ARFGEF3 TAS2R5 SUGP2 NLRC5 CPLANE1 DNAH11 | 9.64e-07 | 552 | 176 | 14 | 10737800 |
| Pubmed | Myogenic repressor I-mfa interferes with the function of Zic family proteins. | 1.26e-06 | 5 | 176 | 3 | 15207726 | |
| Pubmed | Molecular properties of Zic4 and Zic5 proteins: functional diversity within Zic family. | 2.52e-06 | 6 | 176 | 3 | 15465018 | |
| Pubmed | Physical and functional interactions between Zic and Gli proteins. | 2.52e-06 | 6 | 176 | 3 | 11238441 | |
| Pubmed | Expression of opioid receptors and ligands in pregnant mouse uterus and placenta. | 2.52e-06 | 6 | 176 | 3 | 9746745 | |
| Pubmed | Zic2 patterns binocular vision by specifying the uncrossed retinal projection. | 4.39e-06 | 7 | 176 | 3 | 13678579 | |
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 9037092 | ||
| Pubmed | Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points. | 4.39e-06 | 7 | 176 | 3 | 19063725 | |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 4.39e-06 | 7 | 176 | 3 | 15710750 | |
| Pubmed | Increased proximal bifurcation of CA1 pyramidal apical dendrites in sema3A mutant mice. | 4.39e-06 | 7 | 176 | 3 | 19655386 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 4.39e-06 | 7 | 176 | 3 | 11353387 | |
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 30944974 | ||
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 4.39e-06 | 7 | 176 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 4.39e-06 | 7 | 176 | 3 | 17372272 | |
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 38657106 | ||
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 21205196 | ||
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 18949001 | ||
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 25187515 | ||
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 8603673 | ||
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 26632511 | ||
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 24403063 | ||
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 23818861 | ||
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 23536549 | ||
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 12191015 | ||
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 22821000 | ||
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 20682751 | ||
| Pubmed | 7.00e-06 | 8 | 176 | 3 | 15661641 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 7.00e-06 | 8 | 176 | 3 | 21670213 | |
| Pubmed | Preimplantation mouse embryo is a target for opioid ligand-receptor signaling. | 7.00e-06 | 8 | 176 | 3 | 24855103 | |
| Pubmed | 7.00e-06 | 8 | 176 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 7.00e-06 | 8 | 176 | 3 | 21310149 | |
| Pubmed | 7.00e-06 | 8 | 176 | 3 | 9070329 | ||
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 7.00e-06 | 8 | 176 | 3 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 7.00e-06 | 8 | 176 | 3 | 28745977 | |
| Pubmed | Integration of opposing semaphorin guidance cues in cortical axons. | 7.00e-06 | 8 | 176 | 3 | 22368082 | |
| Pubmed | 7.00e-06 | 8 | 176 | 3 | 31638440 | ||
| Pubmed | The role of Zic genes in inner ear development in the mouse: Exploring mutant mouse phenotypes. | 1.05e-05 | 9 | 176 | 3 | 25178196 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 1.05e-05 | 9 | 176 | 3 | 18394993 | |
| Pubmed | 1.05e-05 | 9 | 176 | 3 | 28100513 | ||
| Pubmed | 1.05e-05 | 9 | 176 | 3 | 19909241 | ||
| Pubmed | 1.05e-05 | 9 | 176 | 3 | 17887960 | ||
| Pubmed | 1.05e-05 | 9 | 176 | 3 | 11553612 | ||
| Pubmed | 1.05e-05 | 9 | 176 | 3 | 10601307 | ||
| Pubmed | 1.05e-05 | 9 | 176 | 3 | 9733766 | ||
| Pubmed | 1.05e-05 | 9 | 176 | 3 | 28877029 | ||
| Pubmed | ABCB7 OBSCN CD55 CUBN NT5DC1 STAT1 ORAI1 RESF1 PLAA PAPOLA ABCE1 LTN1 PIGW ATP11A EIF2AK4 OTULINL CPLANE1 VPS13B | 1.09e-05 | 1084 | 176 | 18 | 11544199 | |
| Pubmed | 1.48e-05 | 61 | 176 | 5 | 20548051 | ||
| Pubmed | A role for Zic1 and Zic2 in Myf5 regulation and somite myogenesis. | 1.49e-05 | 10 | 176 | 3 | 21211521 | |
| Pubmed | 1.49e-05 | 10 | 176 | 3 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 1.49e-05 | 10 | 176 | 3 | 16332688 | |
| Pubmed | Plexin A3 and plexin A4 convey semaphorin signals during facial nerve development. | 1.49e-05 | 10 | 176 | 3 | 18804103 | |
| Pubmed | 1.49e-05 | 10 | 176 | 3 | 15136147 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 1.49e-05 | 10 | 176 | 3 | 8857542 | |
| Pubmed | 1.49e-05 | 10 | 176 | 3 | 21859863 | ||
| Pubmed | 2.04e-05 | 11 | 176 | 3 | 18547559 | ||
| Pubmed | 2.04e-05 | 11 | 176 | 3 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 2.04e-05 | 11 | 176 | 3 | 35771867 | |
| Pubmed | Fibroblast growth factor 8 organizes the neocortical area map and regulates sensory map topography. | 2.04e-05 | 11 | 176 | 3 | 22623663 | |
| Pubmed | 2.04e-05 | 11 | 176 | 3 | 34110283 | ||
| Pubmed | Transcription factors Zic1 and Zic2 bind and transactivate the apolipoprotein E gene promoter. | 2.55e-05 | 2 | 176 | 2 | 11038359 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 11257495 | ||
| Pubmed | Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. | 2.55e-05 | 2 | 176 | 2 | 8393575 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 24278116 | ||
| Pubmed | Zic-Proteins Are Repressors of Dopaminergic Forebrain Fate in Mice and C. elegans. | 2.55e-05 | 2 | 176 | 2 | 28972122 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 12522805 | ||
| Pubmed | Vascular endothelial growth factor activates STAT proteins in aortic endothelial cells. | 2.55e-05 | 2 | 176 | 2 | 10961983 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 11316510 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 23424651 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 39358345 | ||
| Pubmed | Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome. | 2.55e-05 | 2 | 176 | 2 | 12895410 | |
| Pubmed | An Exceptional Gene: Evolution of the TSPY Gene Family in Humans and Other Great Apes. | 2.55e-05 | 2 | 176 | 2 | 24710137 | |
| Pubmed | Structure and function of TSPY, the Y-chromosome gene coding for the "testis-specific protein". | 2.55e-05 | 2 | 176 | 2 | 9678360 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 12486185 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 17622222 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 11040053 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 8244388 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 19176370 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 35241726 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 8922996 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 16331961 | ||
| Pubmed | Identification of kappa- and delta-opioid receptor transcripts in immune cells. | 2.55e-05 | 2 | 176 | 2 | 7649271 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 9325061 | ||
| Pubmed | Common Variants Near ZIC1 and ZIC4 in Autopsy-Confirmed Multiple System Atrophy. | 2.55e-05 | 2 | 176 | 2 | 35997131 | |
| Pubmed | Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist. | 2.55e-05 | 2 | 176 | 2 | 24923251 | |
| Interaction | C3orf18 interactions | KNTC1 DYNC2H1 USP24 STAT1 THADA PLAA LTN1 INTS4 EXOC7 HEATR3 | 5.14e-08 | 115 | 171 | 10 | int:C3orf18 |
| Interaction | TSPY8 interactions | 6.00e-07 | 3 | 171 | 3 | int:TSPY8 | |
| Interaction | SIGLECL1 interactions | 5.48e-06 | 113 | 171 | 8 | int:SIGLECL1 | |
| Interaction | SEMA5A interactions | 2.05e-05 | 7 | 171 | 3 | int:SEMA5A | |
| Cytoband | Yp11.2 | 8.34e-08 | 94 | 176 | 7 | Yp11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYp11 | 2.00e-06 | 150 | 176 | 7 | chrYp11 | |
| GeneFamily | Plexins | 1.94e-05 | 9 | 113 | 3 | 683 | |
| GeneFamily | Opioid receptors | 2.30e-04 | 4 | 113 | 2 | 245 | |
| GeneFamily | Ubiquitin specific peptidases | 4.14e-04 | 56 | 113 | 4 | 366 | |
| Coexpression | GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP | 6.48e-06 | 198 | 171 | 9 | M6025 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-07 | 169 | 176 | 8 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.90e-07 | 189 | 176 | 8 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | facs-MAT-Fat-3m-Epithelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 93 | 176 | 6 | dbfaa7f23d25f5c286ab7ca3ca795b734cb95153 | |
| ToppCell | facs-MAT-Fat-3m-Epithelial-epithelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 93 | 176 | 6 | 0d6d1d8dd9c91ba31eb35a4b5979d087890936c1 | |
| ToppCell | facs-MAT-Fat-3m-Epithelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 93 | 176 | 6 | abffb1fd5a919b7c08e62e1c3c08a8dd8783a4ca | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.97e-06 | 156 | 176 | 7 | 0b3630fd4479291599e1674e87eba6f93877ac3a | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.09e-06 | 157 | 176 | 7 | bd45590da540a557dc8096980a45220fccb99505 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.09e-06 | 157 | 176 | 7 | 00c9a58b033b8b95b0d838f233dd077b62d8b02a | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-intermediate_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.23e-06 | 158 | 176 | 7 | b35bab2b93d0af821bfae18a358eb7dddaf3860f | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.23e-06 | 158 | 176 | 7 | 7bd4a64a610eb1cbcd3d07ea5258a55107cf6c00 | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-06 | 175 | 176 | 7 | b4f01e7782cdd107d0817ef601891fd3a382bc35 | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-06 | 175 | 176 | 7 | ef6f811d8e1839f405c3b41090ddf79be57a099f | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-06 | 175 | 176 | 7 | 7f7598d46d10bff1cbea42f950bdde1aaa16e9a4 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.07e-06 | 178 | 176 | 7 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-06 | 181 | 176 | 7 | 57f0cc749ae8b6a3d77e2af31f9a6e4739c57049 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-06 | 181 | 176 | 7 | d01b35cc2fc57991a35be6a06cb7351fbabd9a11 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-06 | 184 | 176 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-06 | 184 | 176 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-06 | 184 | 176 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.77e-06 | 184 | 176 | 7 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 188 | 176 | 7 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 191 | 176 | 7 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.46e-05 | 199 | 176 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.46e-05 | 199 | 176 | 7 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.51e-05 | 200 | 176 | 7 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.51e-05 | 200 | 176 | 7 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-05 | 156 | 176 | 6 | 3f0b9e35d4da85c90759b930052e5b9c3cde9b15 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-05 | 156 | 176 | 6 | 69e6e8810d1738a66c9821910f41498931cf30cc | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 160 | 176 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 160 | 176 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tregs|GI_large-bowel / Manually curated celltypes from each tissue | 4.54e-05 | 162 | 176 | 6 | 9a5e65c45f73a6a685b8362aa2e6aea77181caa3 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Poorly_Differentiated_or_Epithelioid_Leiomyosarcoma-7|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.60e-05 | 99 | 176 | 5 | 4f0346fe85ba006d1ab28a61624568522ffe5cb4 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-05 | 163 | 176 | 6 | 385b24e18df5ef92108483de312d6c85a1e6d145 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-05 | 163 | 176 | 6 | 8004cc0b3428be08b89957b563cd8799f822d931 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial-RGCs_early_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 5.03e-05 | 165 | 176 | 6 | e460e03992781073cd836a655f15dda3157cea55 | |
| ToppCell | Monocytes-IFN-activated_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.19e-05 | 176 | 176 | 6 | 6a4b403ee3e4dc4f23fbd7a154011e41fd429a9e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.19e-05 | 176 | 176 | 6 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.42e-05 | 177 | 176 | 6 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-05 | 179 | 176 | 6 | e6224864eb76a2e9c1fc0c61513d9e936bb5c72c | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-05 | 179 | 176 | 6 | 9863ab3ceb160a4b1d9790033a4ac48845863d65 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-05 | 179 | 176 | 6 | dfe110add7228cd834b35916cbcc849769a01bb9 | |
| ToppCell | Adult-Immune-T_lymphocyte-D122|Adult / Lineage, Cell type, age group and donor | 8.14e-05 | 180 | 176 | 6 | 06c371d0f0c5a7b234dd143e98800e19af95a8b5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.39e-05 | 181 | 176 | 6 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-7|TCGA-Prostate / Sample_Type by Project: Shred V9 | 8.65e-05 | 182 | 176 | 6 | af16334fec2c757b03c84cf252d00e92fa81e4cd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.92e-05 | 183 | 176 | 6 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.92e-05 | 183 | 176 | 6 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.19e-05 | 184 | 176 | 6 | ed7a8e79e5723a5f5a03f542203d9e50bdef5f50 | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 9.19e-05 | 184 | 176 | 6 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-05 | 184 | 176 | 6 | b998803180322a5ea2b567928dea531c26816c3c | |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | 9.47e-05 | 185 | 176 | 6 | 1979d189c204f4c2893e3170a514ee7d5523406c | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.75e-05 | 186 | 176 | 6 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.75e-05 | 186 | 176 | 6 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | IPF-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 9.75e-05 | 186 | 176 | 6 | d436ee6cabbde8553ec5e6e55022274090d9f41a | |
| ToppCell | Thalamus|World / BrainAtlas - Mouse McCarroll V32 | 9.77e-05 | 116 | 176 | 5 | 5ddfb2dd5459ff6d7ae38163a38eae64fda283b7 | |
| ToppCell | CF|World / Disease state, Lineage and Cell class | 1.00e-04 | 187 | 176 | 6 | eec4d4e4a658e3a61c05745167a1a5e3d39bb43e | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.00e-04 | 187 | 176 | 6 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | multiciliated|World / shred by cell class for bronchial biopsy | 1.03e-04 | 188 | 176 | 6 | 6833c1f0f265ef5448fa65033550ed7efc2f8d7b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-04 | 188 | 176 | 6 | d9692b6048d9b85524a07a1807bdd4757731c151 | |
| ToppCell | COPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 1.10e-04 | 190 | 176 | 6 | aece860b5609ad5a8fc920d685f0d0ec71bf9018 | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.10e-04 | 190 | 176 | 6 | b4088128f5acf53f43244c9af9fe44e033f1a57a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 190 | 176 | 6 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-04 | 190 | 176 | 6 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-04 | 191 | 176 | 6 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 192 | 176 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-04 | 193 | 176 | 6 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.19e-04 | 193 | 176 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.19e-04 | 193 | 176 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | COPD-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 1.19e-04 | 193 | 176 | 6 | 0020249fa71afb500af73700543bb6f349be6b10 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.19e-04 | 193 | 176 | 6 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-04 | 194 | 176 | 6 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.23e-04 | 194 | 176 | 6 | e237384b02be460d44eeada3026a5691c66f6fc1 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.23e-04 | 194 | 176 | 6 | 0bc83ae79873a5e473e6e1e3111924cd003986a1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 194 | 176 | 6 | e55dc30e200c9f576804acb642175eb4fa9146b5 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.26e-04 | 195 | 176 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.26e-04 | 195 | 176 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.26e-04 | 195 | 176 | 6 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Krt73-Inhibitory_Gad1Gad2_Htr3a.Krt73_(Interneuron,__(candidate_CGE-derived_8))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.27e-04 | 65 | 176 | 4 | a3aac8aada31451c33165257773daaae676ad04e | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Krt73|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.27e-04 | 65 | 176 | 4 | 02e778b500f62e5fb70e2f7d493a0280980e6a24 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Krt73-Inhibitory_Gad1Gad2_Htr3a.Krt73_(Interneuron,__(candidate_CGE-derived_8))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.27e-04 | 65 | 176 | 4 | af69f27937e6c55ae937f16c418ff267c3ba6a8a | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.30e-04 | 196 | 176 | 6 | 9a91a6e5f93ce3bb5a0fc63677553f4c2df95c43 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.33e-04 | 197 | 176 | 6 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.33e-04 | 197 | 176 | 6 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | Bronchial_Brush-Epithelial|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.33e-04 | 197 | 176 | 6 | 272c7f4e582ef57564450540242b0db766b78328 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.33e-04 | 197 | 176 | 6 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | Sigmoid-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 1.37e-04 | 198 | 176 | 6 | 305d7ae9b070ac7211638a5282374c02bf13af40 | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 1.37e-04 | 198 | 176 | 6 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.41e-04 | 199 | 176 | 6 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.41e-04 | 199 | 176 | 6 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | mLN-(5)_Dendritic_cell-(54)_pDC|mLN / shred on region, Cell_type, and subtype | 1.41e-04 | 199 | 176 | 6 | 1e738219784a446ee8b0ddeb408e0050e1929e60 | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.41e-04 | 199 | 176 | 6 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | mLN-Dendritic_cell-pDC|mLN / Region, Cell class and subclass | 1.41e-04 | 199 | 176 | 6 | 54f1abb57af7bf8a8b82a38b933f257df3b5d8df | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.41e-04 | 199 | 176 | 6 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.44e-04 | 126 | 176 | 5 | 69b2525b92d1c7c35b21cc701f5fa52a9c1b94bb | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.44e-04 | 126 | 176 | 5 | 6cb89754010d64875e115da6c5805efac7a4a82d | |
| ToppCell | Control-Control-Myeloid-Neutrophil|Control / Disease, condition lineage and cell class | 1.45e-04 | 200 | 176 | 6 | 95c41f147a1594d49e73cb56d86d301c3115ce20 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.45e-04 | 200 | 176 | 6 | 881ab995c90d75fd987d6e8f1f926a4bfcc4235f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.45e-04 | 200 | 176 | 6 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.45e-04 | 200 | 176 | 6 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.45e-04 | 200 | 176 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.45e-04 | 200 | 176 | 6 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| Drug | AC1MLTDX | 3.45e-08 | 27 | 165 | 6 | CID003250242 | |
| Drug | indolin-3-one | 3.74e-07 | 3 | 165 | 3 | CID000230915 | |
| Drug | AC1L5BQM | 1.49e-06 | 4 | 165 | 3 | CID000174892 | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; MCF7; HT_HG-U133A | DENND5B BIN1 EHBP1L1 GRK2 ATP11A PSME3 BAIAP2 DOCK6 IL2RB VPS13B | 1.83e-06 | 197 | 165 | 10 | 5643_DN |
| Drug | Tyr-w-mif-1 | 3.41e-06 | 15 | 165 | 4 | CID000132632 | |
| Drug | oxymorphamine | 3.70e-06 | 5 | 165 | 3 | CID000134844 | |
| Drug | Sc 39566 | 3.70e-06 | 5 | 165 | 3 | CID000130018 | |
| Drug | E-2078 | 4.52e-06 | 16 | 165 | 4 | CID000122220 | |
| Drug | NIH10236 | 7.36e-06 | 6 | 165 | 3 | CID006439828 | |
| Drug | beta-methyl-2',6'-dimethyltyrosine | 7.36e-06 | 6 | 165 | 3 | CID000189865 | |
| Drug | DuP 747 | 7.36e-06 | 6 | 165 | 3 | CID000132447 | |
| Drug | tifluadom | 1.18e-05 | 20 | 165 | 4 | CID000115208 | |
| Drug | Tyr-ala-phe-gly | 1.28e-05 | 7 | 165 | 3 | CID005487532 | |
| Drug | EET-HO | 1.28e-05 | 7 | 165 | 3 | CID000135928 | |
| Drug | MET-CAMO | 1.28e-05 | 7 | 165 | 3 | CID006450159 | |
| Drug | sodium 4-phenylbutyrate; Up 200; 100uM; MCF7; HG-U133A | 1.42e-05 | 197 | 165 | 9 | 341_UP | |
| Drug | C35H51N9O8 | 1.45e-05 | 21 | 165 | 4 | CID003806994 | |
| Drug | phenazocine | 2.04e-05 | 8 | 165 | 3 | CID000014706 | |
| Drug | Tyr-D-Ala-Gly-Phe-Leu-chloromethyl ketone | 2.04e-05 | 8 | 165 | 3 | CID005492572 | |
| Drug | U 69593 | 2.04e-05 | 8 | 165 | 3 | ctd:C045444 | |
| Drug | AC1L2Y8M | 2.04e-05 | 8 | 165 | 3 | CID000130908 | |
| Drug | N-methyl nalorphine | 2.04e-05 | 8 | 165 | 3 | CID005748235 | |
| Drug | Oxymorphone hydrazone | 2.04e-05 | 8 | 165 | 3 | CID009577748 | |
| Drug | H-Tyr-Tic-Phe-Phe-OH | 2.52e-05 | 24 | 165 | 4 | CID000644210 | |
| Drug | AC1L4LFZ | 2.52e-05 | 24 | 165 | 4 | CID000187741 | |
| Drug | Deltakephalin | 2.52e-05 | 24 | 165 | 4 | CID000119319 | |
| Drug | Podophyllotoxin [518-28-5]; Up 200; 9.6uM; HL60; HT_HG-U133A | 2.93e-05 | 166 | 165 | 8 | 2540_UP | |
| Drug | tetrahydro-3-isoquinolinecarboxylic acid | 2.99e-05 | 25 | 165 | 4 | CID000095489 | |
| Drug | Dam K | 3.04e-05 | 9 | 165 | 3 | CID005487344 | |
| Drug | Syndyphalin | 3.04e-05 | 9 | 165 | 3 | CID000174117 | |
| Drug | M 285 | 3.04e-05 | 9 | 165 | 3 | CID000020435 | |
| Drug | MRZ 2549 | 3.04e-05 | 9 | 165 | 3 | CID000134837 | |
| Drug | me fit | 4.32e-05 | 10 | 165 | 3 | CID000127921 | |
| Drug | Bd 737 | 4.32e-05 | 10 | 165 | 3 | CID000131252 | |
| Drug | Naloxone-6-hydrazone | 4.32e-05 | 10 | 165 | 3 | CID009576788 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 5.22e-05 | 180 | 165 | 8 | 5950_UP | |
| Drug | erinacine E | 5.22e-05 | 2 | 165 | 2 | CID005317180 | |
| Drug | Dynorphin (1-11) | 5.22e-05 | 2 | 165 | 2 | CID003086114 | |
| Drug | Tipv | 5.22e-05 | 2 | 165 | 2 | CID000125072 | |
| Drug | (-)-EKC | 5.22e-05 | 2 | 165 | 2 | CID000042800 | |
| Drug | 2-aminooxazole | 5.22e-05 | 2 | 165 | 2 | CID000558521 | |
| Drug | MR-1353 | 5.22e-05 | 2 | 165 | 2 | CID000197198 | |
| Drug | Enkephalin, Methionine | 5.22e-05 | 2 | 165 | 2 | ctd:D004744 | |
| Drug | trefentanil | 5.22e-05 | 2 | 165 | 2 | CID000060727 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 5.42e-05 | 181 | 165 | 8 | 3688_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 5.64e-05 | 182 | 165 | 8 | 6316_UP | |
| Drug | Trimu-5 | 5.91e-05 | 11 | 165 | 3 | CID005487273 | |
| Drug | AC1MI02C | 5.91e-05 | 11 | 165 | 3 | CID003035838 | |
| Drug | AC1MICD4 | 5.91e-05 | 11 | 165 | 3 | CID003021990 | |
| Drug | AC1LCENG | 5.91e-05 | 11 | 165 | 3 | CID000626667 | |
| Drug | etorphine | 6.87e-05 | 59 | 165 | 5 | CID000026721 | |
| Drug | SNC80 | 7.18e-05 | 31 | 165 | 4 | CID000123924 | |
| Drug | Tedam | 7.84e-05 | 12 | 165 | 3 | CID000124900 | |
| Drug | Tedapge | 7.84e-05 | 12 | 165 | 3 | CID000146381 | |
| Drug | dihydroetorphine | 7.84e-05 | 12 | 165 | 3 | CID000107765 | |
| Drug | Mr 1452 | 7.84e-05 | 12 | 165 | 3 | CID000431326 | |
| Drug | ecadotril | 9.24e-05 | 33 | 165 | 4 | CID000060561 | |
| Drug | Oxolinic acid [14698-29-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 9.47e-05 | 196 | 165 | 8 | 2103_DN | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A | 9.47e-05 | 196 | 165 | 8 | 2086_UP | |
| Drug | Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 9.47e-05 | 196 | 165 | 8 | 3534_DN | |
| Drug | (-)-depudecin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 9.47e-05 | 196 | 165 | 8 | 982_DN | |
| Drug | Bicuculline (+) [485-49-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 2796_DN | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 3515_DN | |
| Drug | etonitazene | 1.01e-04 | 13 | 165 | 3 | CID000013493 | |
| Drug | AC1MIXC3 | 1.01e-04 | 13 | 165 | 3 | CID003081671 | |
| Drug | cyprodime hydrobromide | 1.01e-04 | 13 | 165 | 3 | CID005748293 | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A_EA | 1.02e-04 | 198 | 165 | 8 | 1042_DN | |
| Drug | arachidonic acid sodium salt; Up 200; 10uM; MCF7; HG-U133A | 1.02e-04 | 198 | 165 | 8 | 441_UP | |
| Drug | NSC612113 | 1.04e-04 | 34 | 165 | 4 | CID000004424 | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 1.05e-04 | 199 | 165 | 8 | 4346_DN | |
| Drug | Ergocryptine-alpha [511-09-1]; Down 200; 7uM; PC3; HT_HG-U133A | 1.05e-04 | 199 | 165 | 8 | 4552_DN | |
| Drug | Thioridazine hydrochloride [130-61-0]; Down 200; 9.8uM; PC3; HT_HG-U133A | 1.05e-04 | 199 | 165 | 8 | 4085_DN | |
| Drug | Delt-I | 1.17e-04 | 35 | 165 | 4 | CID000123878 | |
| Drug | ethanol | POLA1 PENK XDH OAS2 NLRP1 CYP39A1 NT5DC1 F11 STAT1 OPRD1 OPRK1 DOCK5 GRK2 SCN4A KDR ALDOA IL2RB | 1.28e-04 | 837 | 165 | 17 | CID000000702 |
| Drug | TDAM | 1.28e-04 | 14 | 165 | 3 | CID000124899 | |
| Drug | naltrindole-5'-isothiocyanate | 1.28e-04 | 14 | 165 | 3 | CID005487327 | |
| Drug | Tdagp | 1.28e-04 | 14 | 165 | 3 | CID005491936 | |
| Drug | quadazocine | 1.28e-04 | 14 | 165 | 3 | CID000115077 | |
| Drug | TRK-820 | 1.28e-04 | 14 | 165 | 3 | CID006445230 | |
| Drug | AC1L4W3O | 1.28e-04 | 14 | 165 | 3 | CID000165109 | |
| Drug | 443C81 | 1.28e-04 | 14 | 165 | 3 | CID000130949 | |
| Drug | tert-butylamine | 1.46e-04 | 37 | 165 | 4 | CID000006385 | |
| Drug | TRK 820 | 1.56e-04 | 3 | 165 | 2 | ctd:C111212 | |
| Drug | Oxycodone | 1.56e-04 | 3 | 165 | 2 | DB00497 | |
| Drug | Hydromorphone | 1.56e-04 | 3 | 165 | 2 | DB00327 | |
| Drug | Codeine | 1.56e-04 | 3 | 165 | 2 | DB00318 | |
| Drug | Carfentanil | 1.56e-04 | 3 | 165 | 2 | DB01535 | |
| Drug | Morphine | 1.56e-04 | 3 | 165 | 2 | DB00295 | |
| Drug | Hydrocodone | 1.56e-04 | 3 | 165 | 2 | ctd:D006853 | |
| Drug | 3-Methylfentanyl | 1.56e-04 | 3 | 165 | 2 | DB01571 | |
| Drug | Heroin | 1.56e-04 | 3 | 165 | 2 | DB01452 | |
| Drug | 3-Methylthiofentanyl | 1.56e-04 | 3 | 165 | 2 | DB01439 | |
| Drug | morphine-7,8-oxide | 1.56e-04 | 3 | 165 | 2 | CID005491901 | |
| Drug | Levorphanol | 1.56e-04 | 3 | 165 | 2 | ctd:D007981 | |
| Drug | Levallorphan | 1.56e-04 | 3 | 165 | 2 | ctd:D007977 | |
| Drug | NSC11411 | 1.56e-04 | 3 | 165 | 2 | CID000408117 | |
| Drug | Buprenorphine | 1.56e-04 | 3 | 165 | 2 | DB00921 | |
| Drug | Levorphanol | 1.56e-04 | 3 | 165 | 2 | DB00854 | |
| Drug | Remifentanil | 1.56e-04 | 3 | 165 | 2 | DB00899 | |
| Drug | Nalbuphine | 1.56e-04 | 3 | 165 | 2 | DB00844 | |
| Disease | Ciliopathies | 1.46e-07 | 110 | 158 | 8 | C4277690 | |
| Disease | orofacial cleft | 4.55e-05 | 37 | 158 | 4 | MONDO_0000358 | |
| Disease | Dandy-Walker syndrome (implicated_via_orthology) | 8.52e-05 | 3 | 158 | 2 | DOID:2785 (implicated_via_orthology) | |
| Disease | brain volume measurement | FAT3 ZSWIM6 ZIC1 ZIC3 ZIC4 CYRIA ZFHX4 RNFT2 SELENOO PKHD1 ASTN2 DNAH11 | 9.24e-05 | 595 | 158 | 12 | EFO_0006930 |
| Disease | heroin dependence (implicated_via_orthology) | 1.70e-04 | 4 | 158 | 2 | DOID:9976 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | EHBP1 SFRP5 DYNC2H1 OBSCN XDH CUBN STAT1 ARAP3 HEATR9 NLRC5 ASTN2 KDR ALDOA SPOCD1 VPS13B PGBD3 | 2.22e-04 | 1074 | 158 | 16 | C0006142 |
| Disease | beta-aminoisobutyric acid measurement | 2.81e-04 | 24 | 158 | 3 | EFO_0010464 | |
| Disease | whole-brain volume | 2.82e-04 | 5 | 158 | 2 | EFO_0005089 | |
| Disease | Ataxia | 3.18e-04 | 25 | 158 | 3 | C0004134 | |
| Disease | dehydroepiandrosterone sulphate measurement | 4.94e-04 | 68 | 158 | 4 | EFO_0007001 | |
| Disease | Blastocyst Disintegration | 5.88e-04 | 7 | 158 | 2 | C0012684 | |
| Disease | Common Migraine | 5.88e-04 | 7 | 158 | 2 | C0338480 | |
| Disease | Embryo Loss | 5.88e-04 | 7 | 158 | 2 | C0752351 | |
| Disease | Embryo Death | 5.88e-04 | 7 | 158 | 2 | C0752350 | |
| Disease | Embryo Resorption | 5.88e-04 | 7 | 158 | 2 | C0013937 | |
| Disease | Embryo Disintegration | 5.88e-04 | 7 | 158 | 2 | C1136082 | |
| Disease | postherpetic neuralgia | 7.81e-04 | 8 | 158 | 2 | MONDO_0041052 | |
| Disease | Male sterility due to Y-chromosome deletions | 7.81e-04 | 8 | 158 | 2 | C2931163 | |
| Disease | Partial chromosome Y deletion | 7.81e-04 | 8 | 158 | 2 | C1507149 | |
| Disease | PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME | 7.81e-04 | 8 | 158 | 2 | C0796250 | |
| Disease | alcohol drinking | 9.56e-04 | 81 | 158 | 4 | EFO_0004329 | |
| Disease | choroid plexus volume measurement | 1.00e-03 | 9 | 158 | 2 | EFO_0010293 | |
| Disease | RETINITIS PIGMENTOSA | 1.25e-03 | 10 | 158 | 2 | 268000 | |
| Disease | physical activity | 1.30e-03 | 88 | 158 | 4 | EFO_0003940 | |
| Disease | opioid dependence | 1.79e-03 | 237 | 158 | 6 | EFO_0005611 | |
| Disease | AL amyloidosis | 1.82e-03 | 12 | 158 | 2 | MONDO_0019438 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 2.14e-03 | 13 | 158 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 2.14e-03 | 13 | 158 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 2.14e-03 | 13 | 158 | 2 | C0410203 | |
| Disease | Myopathy, Centronuclear, 1 | 2.14e-03 | 13 | 158 | 2 | C4551952 | |
| Disease | Congenital Structural Myopathy | 2.14e-03 | 13 | 158 | 2 | C0752282 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 2.49e-03 | 14 | 158 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 2.49e-03 | 14 | 158 | 2 | C0410207 | |
| Disease | peptide measurement | 2.85e-03 | 109 | 158 | 4 | EFO_0010520 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 2.86e-03 | 15 | 158 | 2 | C3645536 | |
| Disease | phospholipids in medium HDL measurement | 3.22e-03 | 55 | 158 | 3 | EFO_0022295 | |
| Disease | Tremor, Rubral | 3.25e-03 | 16 | 158 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 3.25e-03 | 16 | 158 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 3.25e-03 | 16 | 158 | 2 | C0278161 | |
| Disease | Ataxia, Sensory | 3.25e-03 | 16 | 158 | 2 | C0240991 | |
| Disease | Abnormal coordination | 3.25e-03 | 16 | 158 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 3.25e-03 | 16 | 158 | 2 | C0427190 | |
| Disease | migraine without aura, susceptibility to, 4 | 3.25e-03 | 16 | 158 | 2 | MONDO_0011847 | |
| Disease | sphingomyelin 14:0 measurement | 3.68e-03 | 17 | 158 | 2 | EFO_0010390 | |
| Disease | total lipids in medium HDL measurement | 3.75e-03 | 58 | 158 | 3 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 3.75e-03 | 58 | 158 | 3 | EFO_0022267 | |
| Disease | cholesterol in medium HDL measurement | 3.93e-03 | 59 | 158 | 3 | EFO_0021903 | |
| Disease | Cleft palate, cleft lip | 4.02e-03 | 279 | 158 | 6 | EFO_0003959, HP_0000175 | |
| Disease | Congenital Fiber Type Disproportion | 4.12e-03 | 18 | 158 | 2 | C0546264 | |
| Disease | free cholesterol in HDL measurement | 4.32e-03 | 61 | 158 | 3 | EFO_0022264 | |
| Disease | phospholipids in HDL measurement | 4.32e-03 | 61 | 158 | 3 | EFO_0022293 | |
| Disease | diet measurement, HOMA-B | 4.59e-03 | 19 | 158 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | total lipids in HDL measurement | 4.73e-03 | 63 | 158 | 3 | EFO_0022307 | |
| Disease | coronary artery disease | EHBP1 CLTCL1 DYNC2H1 DEFB127 ZNF722 NEDD9 DOCK5 THADA EHBP1L1 PKHD1 SHOC1 ASTN2 DOCK6 FBXO21 | 5.04e-03 | 1194 | 158 | 14 | EFO_0001645 |
| Disease | prostate adenocarcinoma (is_implicated_in) | 5.08e-03 | 20 | 158 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | Familial aplasia of the vermis | 5.08e-03 | 20 | 158 | 2 | cv:C0431399 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ICLDILKDKWSPALQ | 86 | P61088 | |
| DLEPKAANCTKILVW | 296 | Q9P2W7 | |
| ECLASKLREKWVINP | 196 | Q7L0X2 | |
| TVPEKTWKQLRRCLQ | 66 | Q5RGS3 | |
| CEKIISTLPSWRKLN | 966 | P53355 | |
| SEEQIAKWDPLCKNI | 131 | Q99424 | |
| AKWDPLCKNIQIIAT | 136 | Q99424 | |
| AKEGLLLWCQRKTAP | 146 | P12814 | |
| ICLRNLQTKEKPWEV | 206 | Q9NZN9 | |
| PKEKVLEQALQWCQL | 1181 | Q8WWN8 | |
| CVWIITALNPSKVIK | 431 | Q7Z408 | |
| WSLNILAINKPQNKC | 511 | Q14511 | |
| WCVEQLELGLKRQKP | 116 | Q9H7E9 | |
| CLDDKERWSPQQLLK | 521 | Q9P2K8 | |
| LCNPALLGEWKQSLK | 301 | Q8NHS2 | |
| AINKCPLLKPWALTF | 286 | P04075 | |
| NPLTWKQLLCDLVGI | 756 | Q9UDR5 | |
| LKALKWELCPVTIIS | 231 | O96020 | |
| CAKLKSALEVQREWP | 511 | Q8WXK1 | |
| ELVHCKWVPFLQQKV | 3431 | Q96DT5 | |
| KIVTWVLNIKKPLCS | 1436 | Q86UQ4 | |
| NPDAWKKQCKELLSL | 1301 | Q6RI45 | |
| KISQQLCGVKKLPWS | 21 | Q99766 | |
| CIILVKPKDVSLWAA | 71 | Q96EU7 | |
| LAQVPLDKWCLNEIL | 46 | Q96BY7 | |
| CIIHFPSKKVQQQLW | 916 | O75129 | |
| QNALLEKPLCPKELW | 201 | Q3KR37 | |
| ILQCDSDPELVQWKK | 631 | P25098 | |
| KLGTQTVPCNKILLW | 111 | P28907 | |
| TVPCNKILLWSRIKD | 116 | P28907 | |
| KEDLCISPGKLVWVL | 121 | Q96B26 | |
| IKALQEKLWNVAAPL | 671 | Q96HW7 | |
| KWNSLLKIIEKACPS | 711 | O94822 | |
| LPSLKIWETCKELLQ | 56 | P01210 | |
| IWETCKELLQLSKPE | 61 | P01210 | |
| LGIWPEKSFCLVLKV | 436 | O94952 | |
| EKAWNAVCPLVVRLK | 76 | Q9H0Q0 | |
| PWKHLIFVLNKCDLV | 246 | Q13823 | |
| SCPESVKKWLRQLKN | 196 | Q5TFE4 | |
| LLDHILWVKVCNPEK | 331 | Q9UQ53 | |
| WKLDLCTTVLPQIEK | 551 | Q9BVA0 | |
| PKLTCLQNLKWSTAV | 141 | P08174 | |
| VVLLCWVKFLPLKKQ | 191 | Q96D31 | |
| LVDGAPLWLLKCQQE | 81 | Q9UK22 | |
| KSNCLPLRFWVNVIK | 1741 | Q9UIW2 | |
| KSNCLPLRFWVNVIK | 1716 | P51805 | |
| LDLAWLKVKDIPCSS | 381 | Q9HCM2 | |
| LGTLLLWLCQAQKKP | 391 | Q8N441 | |
| LVKSNKELWALCLVP | 506 | Q9C000 | |
| IIVLWKCLRKPVLND | 221 | P34910 | |
| LCKQKPADPLIWLAD | 176 | P56597 | |
| QKKWKPLEFLLCTLA | 36 | Q6NV75 | |
| ELVLECTKKWQPDKL | 26 | Q8N3D4 | |
| KWLKEVEAENLLGLC | 186 | Q8N7G0 | |
| SLQKLCPWFKNDVIP | 596 | P50748 | |
| LFQKPTVTEQLKKCW | 11 | Q9H1M4 | |
| WHQQCQKKIKDLPSL | 206 | P29728 | |
| GNVPNEKIAIWLKDC | 71 | P28290 | |
| WIVQCAPNKKLPIEL | 21 | Q8TCD6 | |
| IVWKKNKSIVCVDPQ | 66 | O43927 | |
| VKSPQLLNQPVSWCK | 501 | P09884 | |
| LCKIQKAWAIPDTEQ | 666 | Q9UPT5 | |
| PFQANSWKNLILKVC | 201 | P51956 | |
| KNLWSCLVRLLTKDP | 11 | Q86WI3 | |
| KLPEKLLFSQGCNWI | 166 | Q9NUU6 | |
| TPAKAKLINICIWVL | 161 | P41143 | |
| FCDVKPLLKLSNQWL | 176 | P0DN82 | |
| LQCELSKAAPVEWRK | 3821 | Q5VST9 | |
| LLKQPEECNLNLPVW | 286 | P51003 | |
| CFVSLWLPTASQKKL | 91 | Q3MJ16 | |
| VLSLDLKPWKCQELD | 681 | Q8IUM7 | |
| LQPALLVHWAKCLQK | 571 | A6NKT7 | |
| KNLNCVWIIIAPVNK | 3181 | O60494 | |
| SALLNQKCPLAWQSK | 4116 | Q8NCM8 | |
| KLCIEVTPQSKIAWI | 36 | P61221 | |
| TIWNLKDIIPCKSQA | 256 | Q7Z4Q2 | |
| LQWSDKPCVPHLLQK | 1271 | Q9H7D0 | |
| CVLWVLKNTEPALLQ | 1256 | Q96HP0 | |
| FLWNKDQDCLKTIPI | 86 | Q9H799 | |
| IWKNLCPALIVILGN | 256 | Q5TH69 | |
| PCIILKIVDGKLWFQ | 3881 | Q8TDW7 | |
| APLLTLKQKQEWICL | 181 | P14784 | |
| LKQKQEWICLETLTP | 186 | P14784 | |
| DQWTISKACGKNLPL | 66 | Q5T5S1 | |
| VNSCLKKNLPVNVRW | 71 | Q9UKJ5 | |
| KKLSNAIITSNPWIC | 946 | Q6ZUT9 | |
| WPKESQRNLCLLKTS | 246 | P03951 | |
| AVCILLQKKPNWATA | 2381 | Q0VDD8 | |
| RKPNASQSLLVWCKE | 441 | Q8NDI1 | |
| GIALTWNITKINPKC | 591 | Q5U623 | |
| SQICSLIWLPKTKEI | 446 | Q86Y33 | |
| QLPECLLRNWSKSKK | 206 | Q9NYL5 | |
| EKRCWDIALGPLKQI | 66 | Q5J8M3 | |
| LPKKQQELCVSGTIW | 2756 | Q8NDH2 | |
| EPKCDGQVLLTQVWK | 61 | O94887 | |
| SLLEKAAPQWCQGKL | 176 | O00499 | |
| NACLKKALPVNVKWL | 131 | Q5VXU3 | |
| KVLKCFSSWVQLEVP | 221 | O94829 | |
| CVQVLDPKSKWRSKI | 281 | Q9BWS9 | |
| NTLEWCLPVIDAKNK | 436 | P48444 | |
| KSPCLWEIQKLQEQR | 146 | Q8N4N8 | |
| SILEKLIKTCPVWLQ | 51 | Q8TB24 | |
| LCKWKKADLTVQPVA | 111 | Q8N328 | |
| PAKWKAQLRCALNKS | 76 | O14896 | |
| TPLKAKIINICIWLL | 171 | P41145 | |
| TVPEKTWKQLRGCLQ | 66 | Q5TZK3 | |
| PALSELKAVICWLQK | 151 | Q96EX2 | |
| LKAVICWLQKGLPFI | 156 | Q96EX2 | |
| NPDITKAWKLICDVS | 301 | P54136 | |
| KDGQLWLCAPQAKQI | 666 | Q93008 | |
| LQPALLVHWAKCLQK | 571 | Q7Z3J3 | |
| AKLWLAKRQNPCLVT | 1441 | Q6YHU6 | |
| LIPWTRFCKENINDK | 536 | P42224 | |
| CAPWLKFKNIIHLIV | 561 | P35499 | |
| KQQASSWLPLLAKRC | 86 | Q5T4F7 | |
| QPALLVHWAKCLQKM | 571 | P0DJD1 | |
| EVLATCLSLWKKQPS | 671 | Q9HCM1 | |
| CSQWLKALLKVPLAP | 636 | Q15572 | |
| EWLPLAQCINGKVLI | 336 | P53041 | |
| TLWAKFKLNRCPTIQ | 116 | Q7Z5D8 | |
| CQWSKDQVNLSPKLI | 246 | Q5FBB7 | |
| SKQPEVCRWNLRKLA | 376 | Q9BVL4 | |
| KNLVSLCTLPTANWK | 606 | Q5VXU9 | |
| TPKQSKVVKAILWLC | 611 | Q8WWX8 | |
| FQNIPKLSKVWLHCE | 251 | Q96PL2 | |
| ELLAVKCKLEPLWSN | 541 | P08F94 | |
| LIKGALVPCSWKLIQ | 401 | Q7Z7B1 | |
| AKALQVWPLIEKRTC | 81 | O75027 | |
| KELLAQKLPLWQQAC | 216 | Q9UQB8 | |
| QKLPLWQQACADPSK | 221 | Q9UQB8 | |
| VLPKDWNILPKCQDQ | 546 | Q0P6D6 | |
| KLLLPWLESQIQEGC | 856 | P53675 | |
| PLWIKATVLCKTGAL | 31 | P58418 | |
| NRDWKPLQCLKVLTM | 206 | O75153 | |
| VLKKVLCRQLWPTAT | 1091 | P98196 | |
| EKCNTVKMWVQLLIP | 131 | P61289 | |
| NKIAEILCKDLWRNP | 276 | A0A494C1R9 | |
| KIAEILCKDLWRNPL | 271 | P0CW01 | |
| PKEKILFINLCQWTR | 61 | Q8WWB5 | |
| IPRVKQTCQKILWKT | 276 | Q9NYW4 | |
| DLPTWLAINKVFCNK | 51 | A0JNW5 | |
| PIKQELSCKWIDEAQ | 246 | O60481 | |
| LSCKWIDEAQLSRPK | 251 | O60481 | |
| KIAEILCKDLWRNPL | 271 | A6NKD2 | |
| EAWQKLCKADGILVP | 356 | Q9NRF8 | |
| IQKTWIKDEPLCAKT | 66 | Q96HI0 | |
| KVLFPSEKICLKWQQ | 91 | Q9H9J4 | |
| KSNEWRLKCIAIGNP | 956 | Q86UP3 | |
| NKIAEILCKDLWRNP | 276 | P0CV99 | |
| DRKILNCWLKGPQQE | 381 | Q6ZTK2 | |
| KIAEILCKDLWRNPL | 271 | Q01534 | |
| PDCDILAVKTAQKLW | 551 | Q7Z392 | |
| QWLITNKKCPICRVD | 971 | Q6ZNA4 | |
| QLDPCENKIKWINFL | 116 | Q96C74 | |
| ALDCDPIWVSVLLKK | 1511 | Q8IWN7 | |
| IVWDLLASICPAKAK | 911 | Q6ZMY3 | |
| LKAWLVSSGCPLQVK | 531 | Q8IX01 | |
| ILCASIDPWIQNKLK | 461 | A2RTY3 | |
| LQILWKAINCPEDIV | 596 | Q9Y263 | |
| CQLPGALVIEVKWTK | 501 | Q2MV58 | |
| ILCWKKVSILKVPNI | 76 | Q8N945 | |
| KLWKEELLQDVCAGL | 476 | P47989 | |
| LKSKAELLLSQCPWK | 126 | Q6NWY9 | |
| IIEKKQPVAFWCNPI | 31 | A0A5A6 | |
| LKDGQLWLCAPQAKQ | 666 | O00507 | |
| KIAEILCKDLWRNPL | 271 | P0CV98 | |
| KIAEILCKDLWRNPL | 271 | P0CW00 | |
| VKLKNLLAPGQCAAW | 236 | Q24JQ0 | |
| CLPKQVAWILATSKV | 266 | Q9H869 | |
| RQPIKQELICKWLAA | 121 | Q8N9L1 | |
| IKQELICKWIEPEQL | 221 | Q15915 | |
| IVLNPHCKLEQKASW | 451 | Q9HCJ5 | |
| VRWKIAKQLCSPVDN | 986 | Q9UPU5 | |
| LLKLPTCWTKRSQIA | 771 | Q7Z7G8 | |
| LITCLEQGKEPWNVK | 61 | A6NK75 | |
| ILPEKIQAWAQKQCP | 96 | Q63HK3 | |
| PVCKNLDTLWKLNAT | 601 | P35968 | |
| KNWKIILCLFIIPLV | 691 | Q7Z2W7 | |
| WIKQCIELLLAVCEK | 2491 | Q9Y4A5 | |
| ALQKLPLCASLWKDQ | 1931 | O60293 | |
| LITCLEQGKEPWNRK | 61 | Q8NEM1 | |
| CIKQELICKWIDPEQ | 251 | O95409 | |
| LICKWIDPEQLSNPK | 256 | O95409 | |
| KPDLITCLEQNKEAW | 61 | A0A1W2PQL4 | |
| LDLLTWQELEKKVCG | 731 | Q5T447 | |
| WVLTAAHCKKPNLQV | 56 | Q92876 |